IONS 8-K 2026-09-23
IONIS PHARMACEUTICALS INC (IONS) 8-K dated 2026-09-23 — accession 0001140361-26-037371.
IONIS PHARMACEUTICALS INC (IONS) is a biotechnology company listed on NASDAQ.
IONIS PHARMACEUTICALS INC filed a 8-K on 2026-09-23. Accession 0001140361-26-037371.
This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported IONS revenue for 2025-12-31 was $943.7M. Net income was -$381.4M. Revenue was up 33.8% from 2024-12-31 to 2025-12-31. IONS currently screens at market cap $12.28B.
Not investment advice. The IONS SEC hub lists recent forms. The stock page is the research view.